Clinical Characteristics and Predictive Factors Analysis of Mycoplasma Pneumoniae Pneumonia Complicated with Pleural

Lianlian Ji1, Liqun Lin2, Jian Ye3

  • 1Department of Pediatrics, The Third Affiliated Hospital of Wenzhou Medical University, Ruian, Zhejiang, China. 15868714301@163.com.

Insights

Identifying children with Mycoplasma pneumoniae pneumonia (MPP) who may develop pleural effusion (PE) is crucial. This study found that immunocompromised status, higher respiratory rates, and elevated inflammatory markers predict PE in pediatric MPP patients.

Area of Science:

  • Pediatric Respiratory Medicine
  • Infectious Diseases
  • Critical Care

Background:

  • Mycoplasma pneumoniae pneumonia (MPP) is a common childhood respiratory illness.
  • Pleural effusion (PE) is a potential complication of MPP, requiring specific management.
  • Identifying risk factors for PE in pediatric MPP is essential for early intervention.

Purpose of the Study:

  • To identify clinical and laboratory risk factors for developing pleural effusion in children with Mycoplasma pneumoniae pneumonia.
  • To develop a predictive model for pleural effusion in pediatric MPP patients.

Main Methods:

  • Retrospective case-control study of 412 children with MPP and 82 with MPP and PE.
  • Analysis of demographic, clinical, and laboratory data.
  • Multivariate logistic regression and ROC curve analysis were employed.

Main Results:

  • Immunocompromised states were more frequent in the MPP+PE group (18.29% vs. 8.98%).
  • Children with PE had higher respiratory rates, lower oxygen saturation, longer fever duration, elevated WBC and ESR at admission.
  • The predictive model for PE demonstrated good performance with an AUC of 0.842.

Conclusions:

  • Specific clinical and laboratory findings at admission can identify pediatric MPP patients at higher risk for pleural effusion.
  • Early identification of high-risk children facilitates timely intervention and management of MPP with PE.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
447
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
274
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
333
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
571
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
453
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.8K